References
- Sibai Baha. Hypertensive disorders in women. WB Saunders, Philadelphia 2001
- Altman D, Carroli G, Duley L, Farrell B, Moodley J, Neilson J, Smith D. Magpie Trial Collaboration Group. Do women with pre-eclampsia, and their babies, benefit from magnesium sulphate? The Magpie Trial: a randomized placebo-controlled trial. Lancet 2002; 359: 1877–1890
- Pan American Health Organization (PAHO). Country Health Data, Haiti 1999
- McCaw-Binns A, Standard-Goldson A, Ashley D, Walker G, MacGillivray I. Access to care and maternal mortality in Jamaican hospitals: 1993–1995. Int J Epidemiol 2001; 30: 796–801
- Centers for Disease Control and Prevention (CDC). State-specific maternal mortality among black and white women–United States, 1987–1996. MMWR 1999; 48: 492–496
- MacKay A P, Berg C J, Atrash H K. Pregnancy-related mortality from preeclampsia and eclampsia. Obstet Gynecol 2001; 97: 533–538
- Perry H. Background document for Hôpital Albert Schweitzer evaluation: Description of Haiti, its health, health services, and health-related behaviors. Hôpital Albert Schweitzer, Haiti 2000
- National High Blood Pressure Education Program Working Group. Report on high blood pressure in pregnancy. Am J Obstet Gynecol 2001; 183: S1–S22
- Zhang J, Yu K F. What's the relative risk? A method of correcting the odds ratio in cohort studies of common outcomes. JAMA 1998; 280: 1690–1691
- Barnes-Josiah D, Myntti C, Augustin A. The “three delays” as a framework for examining maternal mortality in Haiti. Soc Sci Med 1998; 8: 981–993
- Sibai B, Dekker G, Kupferminc M. Pre-eclampsia. Lancet 2005; 365: 785–799
- Sibai B M, Mercer B, Sarinoglu C. Severe preeclampsia in the second trimester: Recurrence risk and long-term prognosis. Am J Obstet Gynecol 1991; 165: 1408–1412
- Coetzee E J, Dommisse J, Anthony J. A randomized controlled trial of intravenous magnesium sulphate versus placebo in the management of women with severe pre-eclampsia. Br J Obstet Gynaecol 1998; 105: 300–303
- The Eclampsia Trial Collaborative Group. Which anticonvulsant for women with eclampsia? Evidence from the Collaborative Eclampsia Trial. Lancet 1995; 345: 1455–1463
- Sibai B M, Villar M A, Mabie M. Acute renal failure in hypertensive disorders of pregnancy. Am J Obstet Gynecol 1990; 162: 777–783
- Drakeley A J, Le Roux P A, Anthony J, Penny J. Acute renal failure complicating severe preeclampsia requiring admission to an obstetric intensive care unit. Am J Obstet Gynecol 2002; 186: 253–256
- Martin J N, Jr, May W L, Magann E F, Terrone D A, Rinehart B K, Blake P G. Early risk assessment of severe preeclampsia: Admission battery of symptoms and laboratory tests to predict likelihood of subsequent significant maternal morbidity. Am J Obstet Gynecol 1999; 180: 1407–1414
- Sibai B M, Garland D, Anderson G D, McCubbin J H. Eclampsia II. Clinical significance of laboratory findings. Obstet Gynecol 1982; 59: 153–157
- Isler C M, Rinehart B K, Terrone D A, Martin R W, Magann E F, Martin J N, Jr. Maternal mortality associated with HELLP (hemolysis, elevated liver enzymes, and low platelets) syndrome. Am J Obstet Gynecol 1999; 181: 924–948
- de Swiet M. Maternal mortality: Confidential enquiries into maternal deaths in the United Kingdom. Am J Obstet Gynecol 2000; 182: 760–766